Individuals

and Cancer Guardian

What Individuals are Saying About Cancer Guardian

Comprehensive Support When You Need It,
Peace of Mind When You Don’t

We all know someone who has been touched by cancer and the devastating impact of such a frightening diagnosis.  Unfortunately, Americans born today have a 50% risk of being diagnosed with cancer during their lifetime.(1)

Cancer Guardian provides a comprehensive program

Finding cancer resources in health care systems is notoriously complicated.  Cancer Guardian provides a comprehensive program, from support services, DNA testing, and technology needed to more effectively manage and navigate the confusing cancer landscape.

Personal hereditary risk

Understanding your personal hereditary risk for developing cancer and having access to comprehensive cancer support is essential for you and your loved ones.  Cancer Guardian will empower you to identify individual genetic risk and provide resources to support  longer, healthier lives.

Time is of the essence in preventing and fighting cancer

Time is of the essence in preventing and fighting cancer. Cancer Guardian provides day one benefits that can be utilized immediately, as well as valuable features that are made available if a cancer diagnosis occurs in the future.

Protect Yourself and Your Family with
Advanced Cancer Support.

Contact Us Lead Individuals

References

1. Lifetime Risk of Developing or Dying from Cancer Basic Facts.  American Cancer Society, 2019.

2. Wamberg Genomic Advisors, Cancer Survey of 204 cancer patients and nonprofessional advocates.  Survey Sampling International (SSI), 2018.

3. Unger, Joseph M., et al. Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical and Physician and Patient Barriers to Cancer Clinical Trial Participation.  JNCI J NATL Cancer Institute, 2019.

4. Family Reach. Annual Report 2016. Family Reach Foundation https://familyreachorg/wp-content/uploads/
2017/05/ frf_2016_annual_report_compressedpdf Accessed July 30, 2017.

5. CancerCare. Cancer Care Patient Access and Engagement Report. New York: CancerCare. 2016.

6. Manchanda, Ranjit, et al.  Population based germline testing for primary cancer prevention.  Oncotarget, 2018, Vol. 9 (No. 69), pp: 33062-33063

7. Waszak, Przemyslaw M. et al.  The Spread of Medical Fake News in Social Media.  Health Policy & Technology Review, Elsevier, 2018.

8. Stephen S. Raab, Dana M. Grzybicki, CA Cancer J. Clin. 2010 May-Jun,60(3): 139-65

9. Raab, Stephen S. MD, et al. Quality in Cancer Diagnosis.  Cancer J. Clinical 2010

10. J. Unger, et al., Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical and Physician Barriers to Cancer Clinical Trial Participation, JNCI J Natl Cancer Inst 2019

11. The State of Cancer Care in America, 2014: A report by the American Society of Clinical Oncology.  Journal of Oncology Practice, 2014; 10(2):120-122

12. Sun Life Stop-Loss Report, 2019.  https://sunlife.showpad.com/share/
7SzmNmJJs1a6msorM0DZA

13. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/cancer-treatment-and-figures/cancer-treatment-and-survivorship-facts-and-figures-2014-2015.pdf

14. Measuring Health-Related Productivity Loss. https://ww.liebertpubl.com/doi/pdf/10.3322/caac.20068.

15. https://www.cancer.org/health.com/content/dam/
corp/web/documents/publication
/CardinalHealth-2018_Oncology_Insights_June.pdf

16.  Wamberg Genomic Advisors Cancer Survey of 204 cancer patients and nonprofessional advocates fielded by Survey Sampling International (SSI), 2018.  Available at: https://www.managedhealthcareexecutive.com/leukemia-and-lymphoma/
most-troubling-part-cancer-treatment-patients

Informational Resources

Menu